Pluri Inc. Operating Lease Right-of-Use Assets
Pluri Inc. (PLUR) had Operating Lease Right-of-Use Assets of $6.16 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-09-10
- 2026-06-30: Operating Lease, Right-of-Use Asset $6.16M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $5.53M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $6.55M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $6.75M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $6.16M 10-K · filed 2026-09-10 |
| 2026-03-31 | $5.53M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $6.55M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $6.75M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $6.90M 10-K · filed 2026-09-10 |
| 2025-03-31 | $7.03M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $6.24M 10-Q · filed 2025-02-11 |
| 2024-09-30 | $6.40M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $6.56M 10-K · filed 2025-09-17 |
| 2024-03-31 | $7.15M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $7.34M 10-Q · filed 2024-02-12 |
| 2023-09-30 | $7.47M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $7.63M 10-K · filed 2024-09-18 |
| 2023-03-31 | $7.80M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $7.88M 10-Q · filed 2023-02-13 |
| 2022-09-30 | $8.07M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $8.27M 10-K · filed 2023-09-12 |
| 2022-03-31 | $8.35M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $8.44M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $573.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $728.00K 10-K · filed 2022-09-21 |
| 2021-03-31 | $904.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.05M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $1.19M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.26M 10-K · filed 2021-09-13 |
| 2020-03-31 | $1.42M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.48M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $1.63M 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |